What Alzheimer's Is Actually Telling Us

The dominant theory of Alzheimer's disease for thirty years was the amyloid hypothesis — that the accumulation of amyloid-beta plaques between neurons caused their death, and that clearing the plaques would halt or reverse the disease. Billions of dollars and dozens of drug trials later, the clinical results have been profoundly disappointing. Drugs that successfully cleared amyloid produced minimal cognitive benefit. Something was missing from the model.

An alternative framing has been gaining serious traction: that Alzheimer's is primarily a disease of energy metabolism, and that the plaques are a downstream consequence rather than the root cause. Brain imaging studies using PET scans show that glucose metabolism in the temporal and parietal lobes begins to decline fifteen to twenty years before any cognitive symptoms appear. The energy failure precedes everything else. The amyloid accumulation may represent a cleanup system overwhelmed by the cellular debris of dying, energy-starved neurons.

The sequence the evidence now suggests: mitochondrial dysfunction → insufficient ATP for synaptic maintenance → synapse retraction → memory encoding failure → progressive cell death → plaque accumulation as a marker of damage already done. This reframes the disease entirely. The question shifts from how to clear the plaques to why the mitochondria failed in the first place.

The answers to that question are nutritional as much as genetic. Insulin resistance in the brain — now sometimes called Type 3 diabetes — impairs glucose uptake by neurons, starving them of their primary energy substrate. Chronic omega-6 dominance shifts neuronal membrane composition toward pro-inflammatory lipids that impair mitochondrial function. Magnesium deficiency reduces Mg-ATP availability in neural tissue. B vitamin deficiencies impair the metabolic pathways that mitochondria run on. These are not exotic risk factors. They are the ordinary nutritional consequences of an ordinary modern diet.